US 11446389
Maytansinoid derivatives, conjugates thereof, and methods of use
granted A61KA61K31/537A61K47/68
Quick answer
US patent 11446389 (Maytansinoid derivatives, conjugates thereof, and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/537, A61K47/68, A61K47/6851, A61P